PharmExec Blog
Follow Us
RSS
Bookstore
Category Archives: Legal
Judge Throws The Book At Former Bristol-Myers Squibb Exec
Media wordsmiths are competing to outdo one another today in punny reporting on the news that ex-BMS exec Andrew Bodnar has been sentenced to write a book about the role he played in the firm’s 2006 reverse-payments case over generic Plavix.
“Pen-ance: Bristol-Myers Exec Gets Two Years of Hard Writing,†The Wall Street Journal Law Blog [...]
Wyeth v. Levine: Disrupting the labeling process
The recent and highly publicized Supreme Court decision in Wyeth v Levine brings into sharp focus an aggressive expansion of risk for pharmaceutical companies. Specifically, the ruling sets a precedent that approval of drug labels by the FDA does not protect against lawsuits in individual states.
While FDA compliance has never been defined as comprehensive shelter [...]
Also posted in Regulatory Leave a comment
Preemption Watch: You've Been Warned
The Supreme Court on Wednesday issued its decision in the much-watched case of Wyeth v. Levine—which many in pharma hoped would firmly establish FDA decisions as a bulwark against common-law liability suits in state courts. The decision, as you’ve no doubt heard already, went against Wyeth. Pharm Exec’s coverage is here. The opinion is here. [...]
Daschle to Spearhead Healthcare Reform
President-elect Barack Obama is moving quickly in selecting former Senate majority leader Tom Daschle as secretary of Health and Human Services. Daschle has been a close advisor to Obama, and now is slated to be the administration’s point person on moving health reform legislation through Congress. Reform advocates consider the selection a sign that the [...]
Pfizer Settles Whistleblower Case for $2.3 Billion